HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia

Transfusion

Volumn 47, Issue 7, 2007, Pages 1296-1305

  Ghevaert, Cedric ^a   Campbell, Kate ^b   Stafford, Prachi ^b   Metcalfe, Paul ^b   Casbard, Angela ^b   Smith, Graham A ^b   Allen, Dave ^b   Ranasinghe, Edmund ^b   Williamson, Lorna M ^b   Ouwehand, Willem H ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PLATELET ANTIGEN 1A ANTIBODY; MATERNAL ANTIBODY; MONOCLONAL ANTIBODY; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ARTICLE; BIOASSAY; BIOLOGICAL ACTIVITY; BLOOD SAMPLING; BRAIN HEMORRHAGE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA; FETUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MOBILIZATION; MONOCYTE; NEWBORN; OUTCOME ASSESSMENT; PREDICTION; PREGNANCY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; ANTIGENS, HUMAN PLATELET; FEMALE; FETOMATERNAL TRANSFUSION; HUMANS; INTRACRANIAL HEMORRHAGES; ISOANTIBODIES; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

EID: 34250637822     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01273.x     Document Type: Article

References (29)

1. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993 329 : 1463 6.
2. Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989 1 : 363 6.
3. Berry JE, Murphy CM, Smith GA, et al. Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens. Br J Haematol 2000 110 : 735 42.
4. Davoren A, Curtis BR, Aster RH, et al. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004 44 : 1220 5.
5. Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998 92 : 2280 7.
6. Jaegtvik S, Husebekk A, Aune B, et al. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. BJOG 2000 107 : 691 4.
7. Durand-Zaleski I, Schlegel N, Blum-Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. Am J Perinatol 1996 13 : 423 31.
8. Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood 1997 89 : 4402 6.
9. Turner ML, Bessos H, Fagge T, et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005 45 : 1945 56.
10. Giovangrandi Y, Daffos F, Kaplan C, et al. Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia. Lancet 1990 336 : 310.
11. Murphy MF, Waters AH, Doughty HA, et al. Antenatal management of fetomaternal alloimmune thrombocytopenia - report of 15 affected pregnancies. Transfus Med 1994 4 : 281 92.
12. Engelfriet CP, Reesink HW, Kroll H, et al. Prenatal management of alloimmune thrombocytopenia of the fetus. Vox Sang 2003 84 : 142 9.
13. Ranasinghe E, Walton JD, Hurd CM, et al. Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol 2001 113 : 40 2.
14. Overton TG, Duncan KR, Jolly M, et al. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol 2002 186 : 826 31.
15. Buscaglia M, Ghisoni L, Bellotti M, et al. Percutaneous umbilical blood sampling: indication changes and procedure loss rate in a nine years' experience. Fetal Diagn Ther 1996 11 : 106 13.
16. Paidas MJ, Berkowitz RL, Lynch L, et al. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol 1995 172 : 475 9.
17. Ghevaert C, Campbell K, Walton J, et al. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 2007 47 : 901 10.
18. Radder CM, Brand A, Kanhai HH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2001 185 : 683 8.
19. Berkowitz RL, Kolb EA, McFarland JG, et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 2006 107 : 91 6.
20. Bertrand G, Martageix C, Jallu V, et al. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 2006 4 : 628 37.
21. Proulx C, Filion M, Goldman M, et al. Analysis of immunoglobulin class, IgG subclass and titre of HPA-1a antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia. Br J Haematol 1994 87 : 813 7.
22. Metcalfe P, Allen D, Chapman J, et al. Interlaboratory variation in the detection of clinically significant alloantibodies against human platelet alloantigens. Br J Haematol 1997 97 : 204 7.
23. Allen D, Rigsby P, Bessos H, et al. Collaborative study to establish the first international standard for quantitation of anti-HPA-1a. Vox Sang 2005 89 : 100 4.
24. Hadley AG. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn. Transplant Immunol 2002 10 : 191 8.
25. Turner CP, Hadley AG. The role of P-selectin in the immune destruction of platelets. Br J Haematol 2003 121 : 623 31.
26. Kiefel V. The MAIPA assay and its applications in immunohaematology. Transfus Med 1992 2 : 181 8.
27. Bugert P, McBride S, Smith G, et al. Microarray-based genotyping for blood groups: comparison of gene array and 5′-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005 45 : 654 9.
28. Bussel JB, Zabusky MR, Berkowitz RL, et al. Fetal alloimmune thrombocytopenia. N Engl J Med 1997 337 : 22 6.
29. Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? J Clin Invest 1997 99 : 2139 51.